Association between post-treatment (tx) alpha-fetoprotein (AFP) reduction and outcomes in real-world (rw) U.S. patients (pts) with advanced HCC (aHCC).
| Publicado en: | Journal of Clinical Oncology Vol. 39; pp. 341 - 342 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2021 Supplement
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183146530&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 183146530 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2021 Supplement vid: 39 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 183146530 10.1200/JCO.2021.39.3_suppl.341 183146530 ppf: 341 ppct: 1 formats: tig: atl: Association between post-treatment (tx) alpha-fetoprotein (AFP) reduction and outcomes in real-world (rw) U.S. patients (pts) with advanced HCC (aHCC). aug: au: Wang, Xiaoliang Magee, Kelly Gossai, Anala Parrinello, Christina M. Miksad, Rebecca A. Kim, Richard D. Abou-Alfa, Ghassan K. affil: Flatiron Health, New York, NY sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|